This new vaccine will be both about 25% more effective than the old vaccine stocks, and will be capable of being sythesized much more rapidly. A double win! Excellent.

The vaccine builds on all the lessons learned during COVID-19 [and we all owe Dr. Fauci a debt of gratitude for the lives spared then and there. This GOP witch hunt is. . . deplorable.] But today’s news is exciting, for all who actually accept the truths of bio-science in public health outreach efforts.

Here’s that, from NBC:

…The Food and Drug Administration on Wednesday approved the U.S.’ first flu shot that uses mRNA technology: mFlusiva, from drugmaker Moderna.

The FDA granted approval for two age groups, adults 50 to 65 and adults 65 and up, on the condition that Moderna run an additional clinical trial in the older group, the company said in a release. In a late-stage trial, mFlusiva was found to be about 27% more effective than a standard flu shot.

Many scientists and public health experts have touted the idea of an mRNA-based flu vaccine, which uses the same messenger RNA platform as the Covid vaccines from Moderna and Pfizer. That’s because mRNA vaccines can be manufactured much faster than traditional vaccines, allowing scientists to better match circulating influenza strains….

Now you know — with Mozart’s unfinished Requiem, under the stars tonight at Pritzker… smile.

नमस्ते